Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.35%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚น189.74 Billion

As of December 2025 Galapagos NV has a market cap of โ‚น189.74 Billion. This makes Galapagos NV the world's 4563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น189.74 B22.95%
2024โ‚น154.32 B-30.79%
2023โ‚น223.00 B-7.77%
2022โ‚น241.77 B-11.08%
2021โ‚น271.90 B-42.58%
2020โ‚น473.53 B-50.85%
2019โ‚น963.38 B174.51%
2018โ‚น350.95 B14.45%
2017โ‚น306.65 B51.43%
2016โ‚น202.50 B23.62%
2015โ‚น163.81 B352.89%
2014โ‚น36.17 B-6.59%
2013โ‚น38.72 B25.14%
2012โ‚น30.94 B63.99%
2011โ‚น18.86 B-1.02%
2010โ‚น19.06 B61.18%
2009โ‚น11.82 B139.45%
2008โ‚น4.93 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Galapagos NV was reported to be:

โ‚น187.01 Billion
by Nasdaq info icon info icon
โ‚น189.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
โ‚น25.119 T 13,138.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น43.706 T 22,934.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.861 T 5,624.04%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น35.895 T 18,817.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚น7.89 B-95.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น19.557 T 10,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.933 T 1,445.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น8.778 T 4,526.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น22.376 T 11,692.81%๐Ÿ‡บ๐Ÿ‡ธ USA